Metronidazole Vaginal Gel 1.3% in the Treatment of Bacterial Vaginosis: A Dose-Ranging Study

OBJECTIVE: Metronidazole vaginal gel (MVG) 0.75% is a US Food and Drug Administration–approved, 5-day treatment for bacterial vaginosis (BV). This study tested the hypothesis that a shorter treatment course at a higher dose (MVG 1.3%) would yield similar efficacy to 5 days of MVG 0.75%. MATERIALS AN...

Descripción completa

Detalles Bibliográficos
Autores principales: Chavoustie, Steven E., Jacobs, Mark, Reisman, Howard A., Waldbaum, Arthur S., Levy, Sharon F., Hillier, Sharon L., Nyirjesy, Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2015
Materias:
Original Articles: Vulva and Vagina
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4376277/
https://www.ncbi.nlm.nih.gov/pubmed/24983350
http://dx.doi.org/10.1097/LGT.0000000000000062

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4376277/
https://www.ncbi.nlm.nih.gov/pubmed/24983350
http://dx.doi.org/10.1097/LGT.0000000000000062

Ejemplares similares